Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Drug Metabolism and Drug Interactions|June 15, 1999
Epidemiology, outcomes research, and drug interactionsJ R ScheinThe Annals of Pharmacotherapy|November 1, 1995
Cigarette smoking and clinically significant drug interactionsJ R ScheinJournal of Clinical Pharmacology|March 28, 2001
Comparative safety of bone remodeling agents with a focus on osteoporosis therapiesM Kleerekoper, J R ScheinSeminars in Arthritis and Rheumatism|February 22, 2001
Osteoporosis therapies for rheumatoid arthritis patients: minimizing gastrointestinal side effectsK Sewell, J R ScheinGastroenterology Clinics of North America|February 7, 2001
Diagnosis and treatment of nonsteroidal anti-inflammatory drug-associated upper gastrointestinal toxicityM S Cappell, J R ScheinArchives of Internal Medicine|October 20, 1998
Maximizing the cost-effectiveness of lipid-lowering therapyT A Jacobson, J R Schein, A Williamson, et al.International Journal of Clinical Practice|November 15, 2014
Incidence of hospital readmission in patients diagnosed with DVT and PE: clinical burden of recurrent eventsE A Nutescu, C Crivera, J R Schein, et al.Women & Health|April 20, 2001
Perceived risks and reported behaviors associated with osteoporosis and its treatmentT Satterfield, S M Johnson, P Slovic, et al.Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|August 24, 1999
A health-related quality of life measure for use in patients with onychomycosis: a validation studyD P Lubeck, D Gause, J R Schein, et al.Journal of the American Podiatric Medical Association|December 16, 1997
Onychomycosis. Baseline results of an observational studyJ R Schein, D Gause, D M Stier, et al.Pageof 2